Product information and disease descriptionProduct descriptionProduct information
Generic, brand name and therapeutic class of product
4 evidence topics · 5 sources
Manufacturer: CG Oncology
Development code and registry intervention names
| Registry field | Quoted record |
|---|---|
| Intervention name | “Cretostimogene Grenadenorepvec” |
| Other name | “CG0070” |
| Intervention description | “Engineered Oncolytic Adenovirus” |
| Co-administered agent | “n-dodecyl-B-D-maltoside” |
| Co-administered agent description | “Transduction-enhancing agent” |
Therapeutic class as described in the pivotal publication and by the company
Brand name
No evidence found.